Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy
- 1 September 2016
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 123 (9) , 1912-1918
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The Effect of Multispot Laser Panretinal Photocoagulation on Retinal Sensitivity and Driving Eligibility in Patients With Diabetic RetinopathyJAMA Ophthalmology, 2016
- Diabetic RetinopathyNew England Journal of Medicine, 2012
- Panretinal Photocoagulation for Proliferative Diabetic RetinopathyNew England Journal of Medicine, 2011
- The Triple Aim: Care, Health, And CostHealth Affairs, 2008
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Angiogenic Pathways in Diabetic RetinopathyNew England Journal of Medicine, 2005
- Long-term Survival Rate after Vitreous Surgery for Complications of Diabetic RetinopathyOphthalmology, 1991
- Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group.1981
- Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study FindingsOphthalmology, 1978
- Preliminary Report on Effects of Photocoagulation TherapyAmerican Journal of Ophthalmology, 1976